Literature DB >> 15006852

Incidence of dry eye in an older population.

Scot E Moss1, Ronald Klein, Barbara E K Klein.   

Abstract

OBJECTIVES: To estimate the 5-year incidence of dry eye and to examine its association with risk factors.
METHODS: The population of Beaver Dam, Wis, that was 43 to 84 years of age (n = 5924) was examined in the 1988-1990 (n = 4926), 1993-1995 (n = 3722), and 1998-2000 study phases (n = 2962). At the 1993-1995 examination, when dry eye data were first collected, and the 1998-2000 examination, 2783 subjects participated, and 44 were interviewed. Of these, 2802 provided dry eye history. The incidence cohort consisted of 2414 subjects not reporting dry eye in the 1993-1995 examination. Risk factor information was ascertained at the 1993-1995 examination and included demographics, medical history, cardiovascular disease risk factors, medications, and lifestyle factors.
RESULTS: During the 5-year interval between examinations, a history of dry eye developed in 322 of 2414 subjects, for an incidence of 13.3% (95% confidence interval [CI], 12.0%-14.7%). Incidence was significantly associated with age (P<.001). After adjusting for age, incidence was greater in subjects with a history of allergy or diabetes, who used antihistamines or diuretics, and with poorer self-rated health (P<.05). Age-adjusted incidence was less in subjects using angiotensin-converting enzyme inhibitors or consuming alcohol (P<.05). It was not significantly associated with sex, blood pressure, hypertension, serum total or high-density lipoprotein cholesterol level, body mass index, history of arthritis, gout, osteoporosis, cardiovascular disease, thyroid disease, or smoking, and use of caffeine, vitamins, antianxiety medications, antidepressants, calcium channel blockers, or anticholesterolemics.
CONCLUSIONS: Incidence of dry eye is substantial. However, there are few associated risk factors. Some drugs (eg, diuretics and antihistamines) are associated with a greater risk, whereas others (angiotensin-converting enzyme inhibitors) are associated with lower risk.

Entities:  

Mesh:

Year:  2004        PMID: 15006852     DOI: 10.1001/archopht.122.3.369

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  70 in total

1.  Low humidity environmental challenge causes barrier disruption and cornification of the mouse corneal epithelium via a c-jun N-terminal kinase 2 (JNK2) pathway.

Authors:  F S A Pelegrino; S C Pflugfelder; C S De Paiva
Journal:  Exp Eye Res       Date:  2011-12-07       Impact factor: 3.467

2.  Spontaneous autoimmune dacryoadenitis in aged CD25KO mice.

Authors:  Ehsan Rahimy; John D Pitcher; Solherny B Pangelinan; Wei Chen; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder; Cintia S De Paiva
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

3.  Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.

Authors:  Min Joung Lee; Ah Young Ko; Jung Hwa Ko; Hyun Ju Lee; Mee Kum Kim; Won Ryang Wee; Sang In Khwarg; Joo Youn Oh
Journal:  Mol Ther       Date:  2014-08-25       Impact factor: 11.454

4.  Corrective Techniques and Future Directions for Treatment of Residual Refractive Error Following Cataract Surgery.

Authors:  Majid Moshirfar; Michael V McCaughey; Luis Santiago-Caban
Journal:  Expert Rev Ophthalmol       Date:  2014-12

5.  Evaluation of patients with dry eye for presence of underlying Sjögren syndrome.

Authors:  Esen Karamursel Akpek; Alena Klimava; Jennifer E Thorne; Don Martin; Kaevalin Lekhanont; Ann Ostrovsky
Journal:  Cornea       Date:  2009-06       Impact factor: 2.651

6.  Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life.

Authors:  Adam J Paulsen; Karen J Cruickshanks; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Ronald Klein; Dayna S Dalton
Journal:  Am J Ophthalmol       Date:  2014-01-02       Impact factor: 5.258

7.  The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease.

Authors:  Munira Hussain; Roni M Shtein; Maxwell Pistilli; Maureen G Maguire; Marko Oydanich; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-08-16       Impact factor: 5.033

8.  Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.

Authors:  Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2011-10-22       Impact factor: 5.258

9.  Essential role for c-Jun N-terminal kinase 2 in corneal epithelial response to desiccating stress.

Authors:  Cintia S De Paiva; Solherny B Pangelinan; Emmanuel Chang; K-C Yoon; William J Farley; De-Quan Li; Stephen C Pflugfelder
Journal:  Arch Ophthalmol       Date:  2009-12

10.  Relationships among Tear Film Stability, Osmolarity, and Dryness Symptoms.

Authors:  Thao N Yeh; Andrew D Graham; Meng C Lin
Journal:  Optom Vis Sci       Date:  2015-09       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.